Clinical trial

A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia

NCT05039489

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-09-09

PhaseNA

Study timeline

Study start (actual)2021-09-09Date precision: day

Registry last updated2024-08-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Antipsychotic drugsDRUG

cTBS（the left temporoparietal cortex as the stimulation target）DEVICE

cTBS （the left cerebellum Crus II as the stimulation target）DEVICE

Sponsors & collaborators

Central South Universitylead sponsor

Mapped research locations

ChangshaChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05039489 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.